TY  - GEN
AU  - Mukhopadhyay,Asima
AU  - Plummer,Elizabeth R
AU  - Elattar,Ahmed
AU  - Soohoo,San
AU  - Uzir,Bisha
AU  - Quinn,Jennifer E
AU  - McCluggage,W Glenn
AU  - Maxwell,Perry
AU  - Aneke,Harriet
AU  - Curtin,Nicola J
AU  - Edmondson,Richard J
TI  - Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survival
SN  - 1538-7445
PY  - 2013///0305
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carboplatin
KW  - administration & dosage
KW  - Carcinoma, Ovarian Epithelial
KW  - Combined Modality Therapy
KW  - DNA Breaks, Double-Stranded
KW  - Enzyme Inhibitors
KW  - Female
KW  - Homologous Recombination
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Middle Aged
KW  - Neoplasms, Glandular and Epithelial
KW  - drug therapy
KW  - Ovarian Neoplasms
KW  - Paclitaxel
KW  - Poly(ADP-ribose) Polymerase Inhibitors
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/0008-5472.CAN-12-0324
ER  -